Lumida
/AZN
⌘K
AstraZeneca PLC

AstraZeneca PLC

AZN
$160.17USD+0.33%+0.53 today

MARKET CAP

134.8B

P/E (TTM)

69.6x

FWD P/E

DAY RANGE

$158 – $162

52W RANGE

$146
$213

AI Summary

Stalk
Sell NowMedium

AZN remains in a Stage 3 downtrend with lower highs and lows under declining EMAs. Supply dominates, and recent rallies are being rejected at resistance. We favor initiating bearish engagements now, selling into the pullback at dynamic EMA resistance.

  • Revenue rose 6% to $25.3B, core EPS up 11%, oncology +15%.
  • 25 Phase III readouts in next 18 months underpin future launches.
  • Farciga and Brilinta facing generic entry, risking material revenue declines.
Full analysis →
Insider Trades5 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
Aug 6, 2026BuyAZNMani SharmaSVP, Group Controller2$163.34$134.8B-24.70%+9.86%$326.68+0.01%Trim
Jul 6, 2026BuyAZNMani Sharma2$190.43$134.8B-24.70%+9.86%$380.86+0.01%Trim
Jun 8, 2026BuyAZNMani Sharma1$179.75$134.8B-24.70%+9.86%$179.75+0.01%Trim
May 20, 2026SellAZNMani Sharma11,893$185.78$134.8B-24.70%+9.86%$2.2M-38.17%Trim
Apr 7, 2026BuyAZNMani Sharma2$191.16$134.8B-24.70%+9.86%$382.31+0.00%Trim